Eashani Sathialingam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eashani Sathialingam has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Erin M. Buckley
The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology/Emory University, Atlanta, USA
2 shared publications - Kyle R. Cowdrick
Georgia Institute of Technology and Emory University, Wallace H. Coulter Department of Biomedical Engineering, Atlanta, Georgia, United States
2 shared publications - Seung Yup Lee
Department of Electrical and Computer Engineering, Kennesaw State University, Marietta, GA, USA
2 shared publications - Ayesha Quadri
Children’s Healthcare of Atlanta and Emory University School of Medicine, Department of Pediatrics, Atlanta, Georgia, United States
1 shared publication - Feras Akbik
Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, USA; Department of Neurology, Division of Neurocritical Care, Emory University School of Medicine, Atlanta, GA, USA
1 shared publication - Hongting Zhao
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA
1 shared publication
Latest Publications
- Open Access
- 1 December 2023
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 28 (12) , 126005-13
Comparison of diffuse correlation spectroscopy analytical models for measuring cerebral blood flow in adults
Diffuse correlation spectroscopy (DCS) is a low-cost, non-invasive optical technology for measuring blood flow. DCS measures the temporal intensity autocorrelation () of multiply scattered light that has traveled from the source to the tissue surface. The decay rate of this curve is related to the motion of red blood cells in the underlying tissue.1,2 Correlation diffusion theory is used to estimate an index of blood flow () from . When DCS is applied in the brain, detected photons that carry information about cerebral hemodynamics have also interacted with extracerebral layers (i.e., skull, scalp, and cerebral spinal fluid) by the nature of the non-invasive measurement. Thus, signal contamination from extracerebral layers is a challenge with DCS.3,4- 1 December 2023
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 28 (12) , 126005-13
Open AccessComparison of diffuse correlation spectroscopy analytical models for measuring cerebral blood flow in adults
Diffuse correlation spectroscopy (DCS) is a low-cost, non-invasive optical technology for measuring blood flow. DCS measures the temporal intensity autocorrelation () of multiply scattered light that has traveled from the source to the tissue surface. The decay rate of this curve is related to the motion of red blood cells in the underlying tissue.1,2 Correlation diffusion theory is used to estimate an index of blood flow () from . When DCS is applied in the brain, detected photons that carry information about cerebral hemodynamics have also interacted with extracerebral layers (i.e., skull, scalp, and cerebral spinal fluid) by the nature of the non-invasive measurement. Thus, signal contamination from extracerebral layers is a challenge with DCS.3,4 - Open Access
- 1 April 2023
- Published by SPIE-Intl Soc Optical Eng in Neurophotonics
- Vol. 10 (02) , 025002-17
Agreement in cerebrovascular reactivity assessed with diffuse correlation spectroscopy across experimental paradigms improves with short separation regression
SignificanceCerebrovascular reactivity (CVR), i.e., the ability of cerebral vasculature to dilate or constrict in response to vasoactive stimuli, is a biomarker of vascular health. Exogenous administration of inhaled carbon dioxide, i.e., hypercapnia (HC), remains the “gold-standard” intervention to assess CVR. More tolerable paradigms that enable CVR quantification when HC is difficult/contraindicated have been proposed. However, because these paradigms feature mechanistic differences in action, an assessment of agreement of these more tolerable paradigms to HC is needed.AimWe aim to determine the agreement of CVR assessed during HC, breath-hold (BH), and resting state (RS) paradigms.ApproachHealthy adults were subject to HC, BH, and RS paradigms. End tidal carbon dioxide (EtCO2) and cerebral blood flow (CBF, assessed with diffuse correlation spectroscopy) were monitored continuously. CVR (%/mmHg) was quantified via linear regression of CBF versus EtCO2 or via a general linear model (GLM) that was used to minimize the influence of systemic and extracerebral signal contributions.ResultsStrong agreement (CCC ≥ 0.69; R ≥ 0.76) among CVR paradigms was demonstrated when utilizing a GLM to regress out systemic/extracerebral signal contributions. Linear regression alone showed poor agreement across paradigms (CCC ≤ 0.35; R ≤ 0.45).ConclusionsMore tolerable experimental paradigms coupled with regression of systemic/extracerebral signal contributions may offer a viable alternative to HC for assessing CVR.
- 1 April 2023
- Published by SPIE-Intl Soc Optical Eng in Neurophotonics
- Vol. 10 (02) , 025002-17
Open AccessAgreement in cerebrovascular reactivity assessed with diffuse correlation spectroscopy across experimental paradigms improves with short separation regression
SignificanceCerebrovascular reactivity (CVR), i.e., the ability of cerebral vasculature to dilate or constrict in response to vasoactive stimuli, is a biomarker of vascular health. Exogenous administration of inhaled carbon dioxide, i.e., hypercapnia (HC), remains the “gold-standard” intervention to assess CVR. More tolerable paradigms that enable CVR quantification when HC is difficult/contraindicated have been proposed. However, because these paradigms feature mechanistic differences in action, an assessment of agreement of these more tolerable paradigms to HC is needed.AimWe aim to determine the agreement of CVR assessed during HC, breath-hold (BH), and resting state (RS) paradigms.ApproachHealthy adults were subject to HC, BH, and RS paradigms. End tidal carbon dioxide (EtCO2) and cerebral blood flow (CBF, assessed with diffuse correlation spectroscopy) were monitored continuously. CVR (%/mmHg) was quantified via linear regression of CBF versus EtCO2 or via a general linear model (GLM) that was used to minimize the influence of systemic and extracerebral signal contributions.ResultsStrong agreement (CCC ≥ 0.69; R ≥ 0.76) among CVR paradigms was demonstrated when utilizing a GLM to regress out systemic/extracerebral signal contributions. Linear regression alone showed poor agreement across paradigms (CCC ≤ 0.35; R ≤ 0.45).ConclusionsMore tolerable experimental paradigms coupled with regression of systemic/extracerebral signal contributions may offer a viable alternative to HC for assessing CVR.